← SynDRA
ALACEPRIL
SynDRA canonical compound SYN0030002 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ACE |
| Mechanism of action | angiotensin converting enzyme inhibitor |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- ACE
- SLC33A1
- LTA4H
- MMP2
- MMP9
- PTGS2
- PTGS1
- F2
- REN
- Ace
- dapE
- blaIMP-1
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 MODULATOR
- SLC33A1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NR1I2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- ADORA2A
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH2
- HRH1
- HDAC6
- GHSR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- cetapril
- DU-1219
- cenapride
- Cetapril
- NSC-338157
- Cetapril (TN)
- Alaceprilum
- DU 1219
- X39TL7JDPF
- NSC 338157
- DTXCID3028502
- aracepril
- RefChem:915340
- C20H26N2O5S
- NCGC00182037-01
- Alaceprilum [Latin]
- Alacepril [INN:JAN]
- UNII-X39TL7JDPF
- BRN 3634372
- MFCD00869538
- ALACEPRIL [INN]
- ALACEPRIL [JAN]
- ALACEPRIL [MI]
- Alacepril (JP18/INN)
- ALACEPRIL [MART.]
- ALACEPRIL [WHO-DD]
- SCHEMBL34559
- orb1299487
- CHEBI:31182
- FHHHOYXPRDYHEZ-COXVUDFISA-N
- Tox21_112904
- MSK168017
- AKOS015916655
- KS-1321
- CAS-74258-86-9
- HY-107318
- CS-0028129
- NS00121309
Reported adverse events
- Angioedema
- Hypotension
- Cardiac arrest
- Myalgia
- Pruritus
- Tachycardia
- Angina pectoris
- Cough
- Flushing
- Neutropenia
- Rash
- Bronchospasm
Look up ALACEPRIL in the interactive SynDRA portal →